Posts

Showing posts with the label Infantile Spasms (IS) competitive landscape

Infantile Spasms (IS) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035

Infantile Spasms (IS) Market Outlook Thelansis’s “Infantile Spasms (IS) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Infantile Spasms (IS) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Key business questions answered: How can drug development and lifecycle management strategies be optimized across G8 markets (US, EU5, Japan, and China)? How large is the patient population in terms of incidence, prevalence, segments, and those receiving drug treatments? What is the 10-year market outlook for sales and patient share? Which events will have the greatest impact on the market’s trajectory? ...

Infantile Spasms (IS) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Infantile Spasms (IS) Market Outlook Thelansis’s “Infantile Spasms (IS) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Infantile Spasms (IS)     treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Infantile Spasms (IS) Overview Infantile spasms, also known as West syndrome, represent a distinct and often devastating form of epilepsy affecting infants. It is characterized by unique seizure episodes called infantile spasms, which manifest as flexor, extensor, or mixed flexor-extensor spasms. These spasms are accompanied by a distinctive electroencephalography (EEG) pattern known as hypsarrhythmia a...

Infantile Spasms (IS) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
 Infantile spasms, also known as West syndrome, represent a distinct and often devastating form of epilepsy affecting infants. It is characterized by unique seizure episodes called infantile spasms, which manifest as flexor, extensor, or mixed flexor-extensor spasms. These spasms are accompanied by a distinctive electroencephalography (EEG) pattern known as hypsarrhythmia and developmental delays or regressions. The syndrome can be categorized into two types based on etiology: symptomatic and cryptogenic. Symptomatic cases are associated with identifiable underlying causes or significant developmental delays preceding the onset of spasms. In contrast, cryptogenic cases lack such clear underlying causes and typically involve normal development before spasms onset. Causes of infantile spasms may stem from prenatal, perinatal, or postnatal factors, with approximately half of the cases attributed to prenatal factors, including central nervous system malformations, intrauterine insults,...

Infantile Spasms (IS) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032

Image
 Infantile spasms (IS), or West syndrome, one of the most recognized types of epileptic encephalopathy, constitutes a distinct and often catastrophic form of epilepsy of early infancy. The disorder presents with a unique seizure type, infantile spasms, characterized by flexor, extensor, and mixed flexor–extensor spasms; distinct electroencephalography (EEG) pattern of hypsarrhythmia; and psychomotor delay/arrest. IS can be classified by two etiologies: symptomatic and cryptogenic. Patients with symptomatic IS have a clearly defined underlying cause and/or significant developmental delay prior to the onset of spasms. In cryptogenic IS, no underlying cause is identified, and normal development is present prior to the onset of spasms. Causes of IS may be prenatal, perinatal, or postnatal. Approximately 50% of cases have a prenatal cause, which includes central nervous system malformations, intrauterine insults, neurocutaneous syndromes such as tuberous sclerosis complex (TSC), metabol...